Jinnan F. Gao

Taiyuan, 030032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Tertiary lymphoid structures in breast cancer: Mechanistic insights, subtype-specific patterns, and therapeutic implications.

Tertiary lymphoid structures in breast cancer: Mechanistic insights, subtype-specific patterns, and therapeutic implications.

Journal: World journal of surgical oncology
Published: March 01, 2026

Qualitative study on body image disturbance in young and middle-aged women with breast cancer in China.

Qualitative study on body image disturbance in young and middle-aged women with breast cancer in China.

Journal: BMJ open
Published: January 27, 2026

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology
Published: November 14, 2025

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients.

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients.

Journal: Frontiers in oncology
Published: July 17, 2025

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial.

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: April 11, 2025

A multi-model machine learning framework for breast cancer risk stratification using clinical and imaging data.

A multi-model machine learning framework for breast cancer risk stratification using clinical and imaging data.

Journal: Journal of X-ray science and technology
Published: February 20, 2025

Psychological distress in Chinese women with benign breast disease and breast cancer during diagnosis: A cross-sectional study.

Psychological distress in Chinese women with benign breast disease and breast cancer during diagnosis: A cross-sectional study.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: November 19, 2024

Patient preferences and willingness to pay for transitional care in breast cancer: a discrete choice experiment.

Patient preferences and willingness to pay for transitional care in breast cancer: a discrete choice experiment.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 27, 2024

High cure rate and satisfaction in patients with periductal mastitis via the latissimus dorsi myocutaneous flap technique: a retrospective study.

High cure rate and satisfaction in patients with periductal mastitis via the latissimus dorsi myocutaneous flap technique: a retrospective study.

Journal: Gland surgery
Published: November 25, 2023

Qualitative study of the perceived experiences and needs coping of primary caregivers of patients with breast cancer during operation in central China.

Qualitative study of the perceived experiences and needs coping of primary caregivers of patients with breast cancer during operation in central China.

Journal: BMJ open
Published: November 01, 2023

S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.

S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.

Journal: Biomarker research
Published: October 07, 2023

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer.

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer.

Journal: The breast journal
Published: July 11, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026